|
Title
|
Published
|
Price
|
|
The Annual SMS & MMS Conference 2003 - Speaker Papers
By: Visiongain
SMS is the biggest profit generating data service for mobile operators and
you need to make sure that you are getting YOUR share!!!
According to the GSM Association 75 billion text messages were sent
|
more...
|
7/10/2003
|
$642.00
|
|
Pricing, Reimbursement & Parallel Trade 2003 - in The European
By: Visiongain
The new conference Pricing, Reimbursement & Parallel Trade 2003 is the
leading comprehensive event to successfully guide you through the maze of
different pricing and reimbursement policies across Europe.
Discover the latest U.K and
|
more...
|
2/25/2003
|
$642.50
|
|
Mobile Content 2003 Speaker Papers
By: Visiongain
Learn how to maximise your company's profit through multi-media content
over wireless devices.
Growth in mobile content expenditure is expected to rise from EUR590
million last year to EUR3.3 billion by 2006,
|
more...
|
5/12/2003
|
$642.50
|
|
Drug Discovery Technology 2003 Visiongain Conference Speaker
By: Visiongain
Identify and assess the key issues in Drug Discovery Technology. Don't miss
this unique opportunity to examine the industry changes. Hear from leading
companies presenting the next generation of drug discovery strategies,
research and technologies.
|
more...
|
5/22/2003
|
$642.50
|
|
The Commercial & Strategic Implications of GPS after SA
By: Visiongain
GPS (Global Positioning System) is the dominant location-based service in
the world today. It is operated and funded by the U.S. Department of
Defence, and provides positioning and timing services for military units,
and a
|
more...
|
2/1/2001
|
$798.40
|
|
The WAP Management Report (Wireless Application Protocol)
By: Visiongain
Would YOU like 1 in-depth source which analysis the potential of WAP and tells you what Users expect? This report answers the following questions: Do you know which services potential WAP users really want? Do
|
more...
|
3/3/2001
|
$919.00
|
|
Pricing & Reimbursement 2002 - Examination of U.S, UK & European Regional Markets for Prescription Pharmaceuticals
By: Visiongain
The new report Pricing and Reimbursement 2002 is the only comprehensive source of
information that will successfully guide you through the maze of different
pricing and reimbursement policies in the U.S, UK and across Europe.
|
more...
|
11/1/2001
|
$1,040.00
|
|
The SARS Report - Worldwide Pharma Analysis May 2003
By: Visiongain
SARS, the severe acute respiratory syndrome, is a global health emergency of
the highest order and it's not at all clear yet if it represents a
commercial opportunity. Scientists are announcing breakneck progress,
including isolation
|
more...
|
5/1/2003
|
$1,118.05
|
|
3G Bulletin
By: Visiongain
The 3G market is begining to take shape, but significant changes are happening every 4 weeks. Normal mangement reports are too slow and magazines don't give you the information that counts. Wouldn't it be perfect
|
more...
|
1/1/2000
|
$1,118.40
|
|
European Cellular Comparisons Report 2001
By: Visiongain
The European Cellular Comparisons report contains data on all the major
European mobile operators in 15 European nations, including Germany, France,
the U.K., Switzerland, Italy, the Netherlands, and many others. Data for
operators includes contact
|
more...
|
7/3/2001
|
$1,299.00
|
|
i-mode in Europe: Gaining Market Momentum
By: Visiongain
The enormous success of i-mode in Japan has led a number of global(predominantly European) operators to directly license the technology. Thislatest visiongain report analyses the performance and market impact ofEuropean i-mode operators.
While i-mode has
|
more...
|
3/11/2005
|
$1,409.00
|
|
Japanese Cellular Market Report 2002
By: Visiongain
With 52% population penetration, mobile data services which far outclass any others in the world, and the establishment of the first 3G network, the significance of the Japanese Cellular Market in 2002 is irrefutable. visiongain's
|
more...
|
1/21/2002
|
$1,471.00
|
|
US/Canada Reimportation Report
By: Visiongain
Glaxo and AstraZeneca are limiting supplies of drugs to Canada - who will be
next?
Will Pfizer or Merck follow suit?
Under US federal regulations, the reimportation of pharmaceutical products
by wholesalers or suppliers
|
more...
|
6/1/2003
|
$1,495.00
|
|
E-Claims - Market Outlook 2002 - 2007
By: Visiongain
E-Claims - Market Outlook 2002 - 2007 provides the most up-to-date and
comprehensive account of the current status and predictions regarding the
development of online insurance and online claims within the insurance
industry.
Given
|
more...
|
4/1/2003
|
$1,552.36
|
|
Future Pain Drugs
By: Visiongain
Strong competition from generics has limited revenues in the pain management market, but changing attitudes towards pain treatment are revitalizing demand for new pain products and administrative techniques.
The industry is addressing this demand by
|
more...
|
8/1/2002
|
$1,556.84
|
|
Public WLAN Forecasts 2003 - 2008
By: Visiongain
There is a growing business need to access existing business applications seamlessly.
With the increasing availability in public spaces, wireless LAN equipment and service markets are poised for significant growth, but by how much.
|
more...
|
11/1/2002
|
$1,572.14
|
|
Network Sharing - A New Route for 3G Services
By: Visiongain
As 3G network roll-out is pushed further and further back, pressure is mounting upon operators to find alternative methods to enable efficient, safe and cost-effective network construction. Many telcos are burdened by large debts relating
|
more...
|
3/7/2001
|
$1,598.00
|
|
Blockbuster Drugs - Create, Develop and Market a Billion Dollar Drug
By: Visiongain
In 1992 only 4 Blockbuster drugs existed. The number jumped in 1998 to
29 and again in 2000 to 55. What is it now? This report will tell you.
In 1991, Blockbusters accounted for
|
more...
|
4/1/2002
|
$1,598.00
|
|
Central Nervous System Report 2002
By: Visiongain
In 2001 CNS therapies held a market share worth in excess on $40 billion - the strongest growth of any therapeutic class with a staggering 17 per cent.
In the US, drug therapies for
|
more...
|
7/1/2002
|
$1,598.00
|
|
Wireless Gaming 2002-2007 - Increasing Revenue Through the Development of mobile gaming
By: Visiongain
"Currently there are around 5 million
wireless games users in Europe but by 2005 this number is set to grow to an astonishing 130 million." You must ensure you capture this market.
How much
|
more...
|
9/1/2002
|
$1,598.00
|
|
The 4G Report - Sidelining the Operators
By: Visiongain
According to a new survey in the latest 4G Report from visiongain, one in five industry experts predict that the first 4G network will go live by 2005.
The findings of the survey include
|
more...
|
9/1/2001
|
$1,598.40
|
|
The BlackBerry Report
By: Visiongain
The Commercial Potential of BlackBerry in Europe
Research shows that corporations around the world are increasingly dependent on email as a means of communication and, at the same time, workers are spending more and more
|
more...
|
1/21/2002
|
$1,598.40
|
|
Eastern Europe Cellular Comparisons Report 2002
By: Visiongain
Eastern Europe Cellular Comparisons Report 2002 is your complete guide to mobile operators in the Eastern Europe region. Containing comprehensive mobile subscriber statistics for 20 countries and over 50 individual operators, the EECC 2002 report
|
more...
|
1/21/2002
|
$1,598.40
|
|
The Visiongain Pharma League Tables 2002
By: Visiongain
With more than 230 pages, 180 Tables and 17 full colour graphs, The
Visiongain Pharma League Tables 2002 provides invaluable information
gathered directly from the leading 50 pharmaceutical companies, relating
to:
Company Growth
Research
|
more...
|
2/1/2002
|
$1,598.40
|
|
Optimising Your Network Sharing Operations (Version 2.2)
By: Visiongain
Network Sharing is happening - that is clear. Regulatory approval has
been granted and operators and vendors are discussing how they can
function as a shared network operation.
This 50+ page report (updated version 2.2)
|
more...
|
3/1/2002
|
$1,598.40
|
|
Title
|
Published
|
Price
|
(0 items)
